Literature DB >> 16354408

Protective effect of Hachimi-jio-gan against renal failure in a subtotal nephrectomy rat model.

Noriko Yamabe1, Takako Yokozawa, Hyun Young Kim, Eun Ju Cho.   

Abstract

The protective effect of Hachimi-jio-gan extract against chronic renal failure in a subtotal nephrectomy rat model was investigated. The level of serum urea nitrogen by nephrectomy was increased over 15 weeks, but the administration of Hachimi-jio-gan at 50 and 200 mg led to the decrease. In addition, the levels of creatinine (Cr), urinary methylguanidine (MG) and MG/Cr were increased, whereas Cr clearance dramatically decreased in nephrectomized rats. However, oral administration of Hachimi-jio-gan extract prevented the elevation of these uremic toxins in serum and urine, and the production of hydroxyl radical. Moreover, nephrectomy led to a significant decline in superoxide dismutase (SOD) and catalase activities, but increased glutathione peroxidase activity compared with normal levels, indicating an abnormal antioxidative system. The increased activity of both SOD and catalase by the oral administration of Hachimi-jio-gan suggested that these enzymes are associated with the protective role of Hachimi-jio-gan extract against oxidative stress by nephrectomy. Moreover, the decrease in serum albumin in nephrectomized control rats was increased and proteinuria was ameliorated by the administration of Hachimi-jio-gan with improved glomerular hyalinosis, interstitial fibrosis and inflammation, suggesting the beneficial effect of Hachimi-jio-gan to prevent glomerular sclerosis and progressive renal fibrosis. This study suggests that Hachimi-jio-gan plays a protective role in the progression of chronic renal failure through the decline in uremic toxins, elevation of antioxidative enzyme activity such as SOD and catalase, and amelioration of histopathological lesions in the kidney.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16354408     DOI: 10.1211/jpp.57.12.0014

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Effect of Hachimijiogan against Renal Dysfunction and Involvement of Hypoxia-Inducible Factor-1α in the Remnant Kidney Model.

Authors:  Hiroshi Oka; Hirozo Goto; Keiichi Koizumi; Shin Nakamura; Koichi Tsuneyama; Yue Zhou; Michiko Jo; Takako Fujimoto; Hiroaki Sakurai; Naotoshi Shibahara; Ikuo Saiki; Yutaka Shimada
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-24       Impact factor: 2.629

Review 2.  Traditional Oriental Medicines and Alzheimer's Disease.

Authors:  Seong Gak Jeon; Eun Ji Song; Dongje Lee; Junyong Park; Yunkwon Nam; Jin-Il Kim; Minho Moon
Journal:  Aging Dis       Date:  2019-04-01       Impact factor: 6.745

3.  Lower risk of ischemic stroke among patients with chronic kidney disease using chinese herbal medicine as add-on therapy: A real-world nationwide cohort study.

Authors:  Hsuan-Shu Shen; Chung-Yi Hsu; Hei-Tung Yip; I-Hsin Lin
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.